Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Sabirnetug by Acumen Pharmaceuticals for Dementia Associated With Alzheimer's Disease: Likelihood of Approval
Sabirnetug is under clinical development by Acumen Pharmaceuticals and currently in Phase I for Dementia Associated With Alzheimer's Disease. According...
Sabirnetug by Acumen Pharmaceuticals for Mild Cognitive Impairment: Likelihood of Approval
Sabirnetug is under clinical development by Acumen Pharmaceuticals and currently in Phase I for Mild Cognitive Impairment. According to GlobalData,...
Sabirnetug by Acumen Pharmaceuticals for Alzheimer's Disease: Likelihood of Approval
Sabirnetug is under clinical development by Acumen Pharmaceuticals and currently in Phase II for Alzheimer's Disease. According to GlobalData, Phase...